[1] 肖珉,常佩芬,赵勇,等.郭维琴教授治疗心血管疾病合并焦虑症的临床经验[J].现代中医临床,2016,23(1):17-20. [2] 于庆云.心理护理在冠心病合并焦虑症患者中的应用[J].中国实用医药,2015,10(2):208-209. [3] 齐艳鹏,李殿芳,王玉柱,等.冠心病介入患者焦虑抑郁状况调查及其预后的相关性研究[J].中西医结合心血管病电子杂志,2015,3(8):189-190. [4] Golimbet VE, Volel BA, Korovaitseva GI,et al.Association of inflammatory genes with neuroticism, anxiety and depression in male patients with coronary heart disease[J].Zh Nevrol Psikhiatr Im S S Korsakova,2017,117(1):74-79. [5] 任世福.氟西汀与罗布麻治疗冠心病合并焦虑症的临床效果探究[J].心理医生,2017,23(1):64-65. [6] 方晓江,钱宝庆,赵芊,等.中西医结合治疗冠心病合并焦虑症临床疗效及不良反应观察[J].中华中医药学刊,2014,32(9):2299-2301. [7] 刘燕,徐良雄,罗菊英. 电话加短信随访对冠心病患者生活质量的影响[J]. 实用预防医学,2016,23(7):797-800. [8] 徐立彦.冠心病不稳定型心绞痛合并焦虑症患者综合治疗34例观察[J].医药前沿, 2013,6(2):105-106. [9] Lutfi MF.Anxiety level and cardiac autonomic modulations in coronary artery disease and cardiac syndrome X patients[J].PLoS One,2017,12(1):170086-170087. [10] 李庆民,刘兴德.冠心病并抑郁患者血浆 NPY、NE、DA、5-HT 的变化及其临床意义[J].中国现代医生,2008,46(1):47-48. [11] 郑桂杰.氟西汀与罗布麻治疗冠心病合并焦虑症的疗效观察[J].临床医药文献电子杂志,2016,3(14):2868-2869. [12] Nasilowska-Barud A, Zapolski T, Barud M,et al.Overt and covert anxiety as a toxic factor in ischemic heart disease in women: the link between psychological factors and heart disease[J].Med Sci Monit,2017,10(23):751-758. [13] 杨继敏,苏亚玲.稳定型冠心病患者血清生化指标与焦虑抑郁状态的相关性研究[J].中国基层医药,2016,23(24):3781-3785. [14] Farahani MA, Ghaffari F, Norouzinezhad F,et al.The effect of utilizing organizational culture improvement model of patient education on coronary artery bypass graft patients' anxiety and satisfaction: theory testing[J].Electr Physic,2016,8(11):3272-3278. [15] 赵海梅,徐春凤,谭翌,等.焦虑对老年冠心病患者心率变异的影响及意义[J].中国慢性病预防与控制,2014,22(1):99-100. [16] Prugger C, Wellmann J, Heidrich J,et al.Regular exercise behaviour and intention and symptoms of anxiety and depression in coronary heart disease patients across Europe: results from the EUROASPIRE III survey[J].Eur J Prev Cardiol,2017,24(1):84-91.